- Spot platinum has just broken through the $1,740.00/oz mark, last quoted at $1,739.81/oz, up 0.19% on the day; Nymex platinum futures main contract is last quoted at $1,754.4/oz, up 0.43% on the day.
- Mink Therapeutics to report Q2 results, host conference call and webcast
- Gogo Q2 2026 turns to net loss of $2 million; revenue slips 2% to $222.8 million vs Q1 2026
- Templeton Emerging Markets Investment Trust answers shareholder questions ahead of AGM
- Largo names James Bannantine co-CEO as Daniel Tellechea retires
- Neogen CEO Nassif Mikheal reports acquisition of 370 common shares worth $4,369.70
- Oklo says Groves isotope test reactor reaches first criticality in Texas
- CRA International says Q2 FY2026 revenue rises to $210.8 million on higher utilization, lower SG&A ratio
- CRA International FY26 Q2 net income rises 11.4% to $13.5 million; revenue climbs 12.8% to $210.8 million
- NetScout Q1 FY2027 revenue rises 13% as government-related Service Assurance orders accelerate, company says
- Montebalito H1 2026 net loss narrows to EUR 900,000; net sales rise 21.97% to EUR 1.36 million
- BRIEF-Nexpoint Real Estate Finance Q2 EPS USD 0.29
- Western Digital Corporation Stock Drops 11% Despite Beating Earnings
- Sui crypto sinks to $0.67, stuck below $1.01 EMA200 level
- SHOPIFY INC. <SHOP.O>: WEDBUSH RAISES TARGET PRICE TO $176 FROM $155
- ZILLOW GROUP, INC. <ZG.O>: BERNSTEIN CUTS TO MARKET-PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $38 FROM $50
- Banzai International plans rebrand as Parabolic Technologies, ticker to change to PARA
- APPLOVIN CORPORATION : WEDBUSH CUTS TARGET PRICE TO $610 FROM $640
- INSULET CORPORATION : BERNSTEIN CUTS TARGET PRICE TO $175 FROM $200
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: WEDBUSH CUTS TARGET PRICE TO $126 FROM $138
- Bed Bath & Beyond Executive Chairman and CEO Marcus Lemonis acquires common shares worth $202,592.94
- HUBSPOT, INC. <HUBS.N>: BERNSTEIN CUTS TO MARKET-PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $220 FROM $381
- DHT forecasts Q3 spot rates booked to date at $152,700 a day for 58% of spot days
- CRA International declares quarterly cash dividend of $0.57 per share
- Pasinex launches tender for 500 DMT of 46% zinc sulphide from Pinargozu mine
- Delcath net income holds at $2.7 million in Q2 FY26; revenue rises 20.25% to $29.1 million vs Q2 FY25
- NetApp acquires VMware disaster recovery firm JetStream Software
- Theriva Biologics doses first patient in VIRAGE2 Phase 2a trial of VCN-01 for metastatic pancreatic cancer
- Ascendis Pharma posts COACH Week 78 achondroplasia program update presentation
- Fox posts fiscal 2026 Q4, full-year earnings release report link
- Principal Asset Management names Daniel Maric head of European distribution
- Ensysce Biosciences completes Cy Biopharma acquisition
- Nano-X Imaging prices USD 8 million registered direct offering at USD 1 per share with warrants
- Sif Holding publishes transcript of Interim Results 2026 webcast
- REVOLUTION MEDICINES, INC. <RVMD.O>: WEDBUSH RAISES TARGET PRICE TO $201 FROM $192.1
- Iovance publishes corporate presentation highlighting Amtagvi TIL therapy rollout and pipeline expansion in solid tumors
- Chegg Q2 FY26 net loss narrows to $3 million; revenue drops 51% to $51.8 million
- Safe Harbor 401(k) plan wins Canopy HR endorsement for cannabis clients
- BlackRock TCP Capital sells $511.9 million investment portfolio in asset transaction
- MBX Biosciences posts corporate presentation on precision peptide programs for endocrine, metabolic diseases
- Fox Q4 FY26 net income slips 3% to $696 million; revenue rises 28% to $4.21 billion
- Oncor Q2 net income rises to $428 million from $259 million
- BRIEF-CRA International Q2 Adjusted EPS USD 2.16
- IMC scales CoreWeave AI cloud use to expand research computing footprint
- VivoSim Labs issues 9,896,718 shares on warrant exercises
- CRA International schedules fiscal Q2 2026 results conference call
- Hertz Q2 FY26 swings to GAAP profit of $64 million; revenue rises 10% to $2.4 billion
- Nano-X Imaging issues warrants to buy 8,000,000 shares at USD 1.15 in registered direct offering
- TXT e-solutions H1 FY26 adjusted net profit rises 32.8% to EUR 17.9 million; revenue increases 20.6% to EUR 228 million
- Chegg Sees 3Q Rev $43M-$44M >CHGG
- Edgewise net loss widens 58.74% to $57.33 million in Q2 FY26
- Praxis Precision net loss widens 17.7% to $83.72 million in Q2 FY26
- MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 million
- Aurinia Q2 net income climbs 74% to $37.4 million; revenue rises 19% to $83.2 million
- VivoSim regains compliance with Nasdaq $2.5 million stockholders’ equity rule
- Ralph Lauren Continues to Expect Cap Expenditures for FY27 of About 4% to 5% of Rev >RL
- Prime Medicine 3Q Loss/Shr 24c >PRME
- Prime Medicine 3Q Loss $42.1M >PRME
- Aligos Therapeutics 2Q Loss $1.5M >ALGS
- Insight Enterprises Q2 FY26 net earnings climb 65% to $77.6 million; net sales rise 15% to $2.4 billion
- Quanterix management participates in Canaccord Genuity Growth Conference fireside chat
- Establishment Labs Q2 FY26 net loss narrows to $11.7 million; revenue rises 31.7% to $67.5 million
- AquaBounty Q2 net loss narrows 52% to $1.63 million
- Helix returns to profit in Q2 FY26 with net income of $22.7 million; revenue rises 21% to $304 million vs Q2 FY25
- Burford Capital Q2 FY26 revenue drops 42% to USD 110.68 million; net income falls 91% to USD 9.48 million
- Delcath Systems 2Q Rev $29.1M >DCTH
- Delcath Systems 2Q Net $2.67M >DCTH
- USA Today net income returns to profit at $9.13 million in Q2 FY26; revenue falls 8.3% to $536.34 million
- White Mountains Insurance 2Q Net $199M >WTM
- Whitehawk Therapeutics 2Q Research and Development Expenses $12.9M >WHWK
- Praxis Precision Med 2Q Loss $83.7M >PRAX
- Praxis Precision Med 2Q Loss/Shr $2.87 >PRAX
- Ralph Lauren Sees 2Q Revenue Growing About Mid-Single Digits on Constant Currency Basis, Centered Around 5% to 6% >RL
- Zillow: US home sales rise 7% in July as pending listings slump 7.7% from June
- Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
- Whitehawk Q2 FY26 net loss narrows to $16.64 million
- Vivani Medical completes dosing in SLIM-1 Phase 1 trial of NPM-139 semaglutide implant for weight management
- Globalstar Q2 FY26 swings to net loss of $26.5 million; revenue falls 5% to $64.8 million
- LEMAITRE VASCULAR, INC. <LMAT.O>: BARRINGTON RESEARCH RAISES TO OUTPERFORM FROM MARKET PERFORM
- Ascendis Pharma posts slide presentation on achondroplasia program updates
- Kratos wins US Army contract to develop next-generation infrared seeker for Javelin missile system
- BRIEF-Chegg Q2 Revenue USD 51.849 Million
- Centrus Energy signs LEU, HALEU enrichment supply deal with X-energy
- vTv Therapeutics Q2 FY26 net loss widens to $13.1 million; R&D expenses more than doubled to $8.8 million
- BlackRock TCP Capital Q2 FY26 net investment income falls to $18.14 million; revenue drops to $40 million
- Hyliion wins USD 41.7 million U.S. Navy contract for multi-megawatt KARNO power modules
- Rallybio swings to Q2 net income of $43.67 million; operating loss narrows to $5.65 million
- SHOPIFY INC. <SHOP.TO>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO C$260 FROM C$240
- Amphenol Adjusts 3Q View To Adj EPS 70c-Adj EPS 71c >APH
- MBX Biosciences 2Q Loss/Shr 78c >MBX
- Aurinia Pharmaceuticals 2Q EPS 28c >AUPH
- Aurinia Pharmaceuticals 2Q Rev $83.2M >AUPH
- Corbus Pharmaceuticals 2Q Loss $35M >CRBP
- Cion Investment Net Asset Value Per Shr Was $13.57 as of June 30 >CION
- Cion Investment 2Q Net Investment Income 29c Per Shr >CION
- Fox Corp. Raises Semi-Annual Dividend to 29c Vs. 28c >FOXA
- Hertz Global 2Q Adj Loss/Shr 11c >HTZ
- Hertz Global 2Q Rev $2.4B >HTZ
- New spot margin trading pair — QUID/USDT!
- New spot margin trading pair — US/USDT!
